Budesonide once versus twice‐daily administration: meta‐analysis
- 1 November 2004
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 9 (4) , 528-534
Abstract
Objectives: The aim of this study was to examine the efficacy of budesonide administered once daily compared to twice daily in asthma.Methodology: Meta‐analysis of randomised controlled trials comparing budesonide administered once versus twice a day that presented data on at least one clinical outcome measure was conducted.Results: A total of 10 studies, with 1922 children and adults with asthma, met the inclusion criteria. These studies were performed predominantly with mild to moderate asthmatic patients, using doses of budesonide ranging from 200 to 800 µg per day. There was no significant difference between daily dosing once or twice for all the clinical outcome variables, including withdrawals due to asthma, for which the odds ratio was 1.0 (95% confidence interval, 0.65–1.52).Conclusions: In mild to moderate asthma a once‐daily budesonide regimen has a similar efficacy to a twice‐daily regimen in doses up to 800 µg per day. A once‐daily regimen has potential advantages in terms of patient compliance and satisfaction, when used in clinical practice.Keywords
This publication has 23 references indexed in Scilit:
- Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available dataAnnals of Allergy, Asthma & Immunology, 2002
- Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroidsAnnals of Allergy, Asthma & Immunology, 2001
- Once-daily use of inhaled corticosteroids: A new regimen in the treatment of persistent asthmaAllergology International, 2000
- Efficacy of once‐daily versus twice‐daily administration of budesonide by Turbuhaler® in children with stable asthmaPediatric Pulmonology, 1999
- Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthmaJournal of Allergy and Clinical Immunology, 1999
- Once-Daily Inhaled Corticosteroids in Mild to Moderate AsthmaDrugs, 1999
- Rationale for Once-Daily Therapy in AsthmaDrugs, 1999
- Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroidsEuropean Respiratory Journal, 1998
- Adverse effects of inhaled budesonide (800 μg) on growth and collagen turnover in children with asthma: A double-blind comparison of once-daily versus twice-daily administrationThe Journal of Pediatrics, 1998
- Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.Thorax, 1995